ETF

Invesco NASDAQ Biotech ETF

ISIN
IE00BQ70R696

How good is this fund, really?

See the rating in the app

About Invesco NASDAQ Biotech ETF

Biotechnology and pharmaceutical stocks listed on the NASDAQ Stock Market form the NASDAQ Biotechnology Index, a modified market-cap-weighted benchmark of roughly 116 components that rebalances quarterly and can include common stocks, ordinary shares, ADRs, shares of beneficial interest and limited partnership interests. Invesco NASDAQ Biotech UCITS ETF aims for its net total return, less costs, without owning the index directly. The fund instead buys a basket of shares, which may sit outside the index, and through unfunded swaps with an approved counterparty receives the index return in exchange for that basket's. It is passive, part of Invesco Markets plc, managed by Invesco Investment Management Limited and based in US dollars. Launched in 2014, this class keeps its income invested. Its key investor information document lists a 0.40% ongoing charge and risk category 6 of 7.

Watch this fund for free Add Invesco NASDAQ Biotech ETF to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Invesco NASDAQ Biotech ETF — platforms and fees

Sold on 3 platforms we follow.

Invesco NASDAQ Biotech ETF — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds